Cancer Research Audrey Hepburn  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 4027-4035, July 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buzzi, M.
Right arrow Articles by Frackelton, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buzzi, M.
Right arrow Articles by Frackelton, A. R., Jr.

Differentiation-induced Changes in Protein-Tyrosine Phosphatase Activity and Commensurate Expression of CD45 in Human Leukemia Cell Lines1

Marina Buzzi2,3,, Li Lu3, Anthony J. Lombardi, Jr., Marshall R. Posner4, David L. Brautigan, Lauren D. Fast and A. Raymond Frackelton, Jr.5

Department of Medicine, Roger Williams Cancer Center [M. B., L. L., A. J. L., M. R. P., A. R. F.], and Department of BioMedical Sciences, Brown University [D. L. B., A. R. F.], and Division of Clinical Hematology, Rhode Island Hospital [L. D. F.], Providence, Rhode Island 02908

Pharmacologic differentiation of the promyelocytic leukemia HL60 is associated with an increase in cellular tyrosine phosphatase activity. We asked (a) if this increase might, at least in part, be due to changes in a transmembranous protein-tyrosine phosphatase, CD45; and (b) if CD45 changes similarly in other differentiating leukemias. Differentiation of HL60, several chronic myelogenous leukemias, a monocytic leukemia (THP-1), and a monoblastoid leukemia (U-937) could be induced by phorbol ester, 1,25-dihydroxy vitamin D3, dimethyl sulfoxide, or cyclic AMP analogues. This differentiation was associated with a marked increase in (a) total cellular tyrosine phosphatase activity (2-4-fold as measured by the ability to dephosphorylate a tyrosine-phosphorylated peptide); (b) CD45-specific tyrosine phosphatase activity (2-4-fold); (c) CD45 cell surface expression by flow cytometry (2-5-fold); (d) synthesis of both exon B-dependent Mr 205,000 and exon ABC- Mr 185,000 CD45 proteins, as revealed by immunoprecipitation with antisera specific for CD45 isoforms. Both isoforms have enhanced electrophoretic mobility when isolated from the differentiated cells. This enhanced mobility did not appear to be due to decreased stoichiometry of CD45 phosphorylation on serine/threonine residues. Interestingly, 12-O-tetradecanoylphorbol-13-acetate transiently reduced CD45 proteintyrosine phosphatase activity in the chronic myelogenous leukemia cell RWLeu4 without altering the CD45 amount (as measured by cell surface immunofluorescence).

Modulation of CD45 tyrosine phosphatase activity (and protein levels) may play a role in differentiation or in maintaining cells in a nonproliferative state or may represent a phenotypic marker of differentiation.

1 Supported in part by National Cancer Institute Cancer Center Grant P30-CA13943-18, by National Cancer Institute Grant RO1-CA39235 (A. R. F.) and by a grant from the Italian Association of Cancer Research (M. B.).

2 Present address: Institute of Hematology, University of Bologna, Bologna, Italy.

3 M. B. and L. L. contributed equally to this work.

4 Present address: Department of Medicine, New England Deaconess Hospital, Boston, MA.

5 To whom requests for reprints should be addressed, at Department of Medicine, Roger Williams General Hospital, Providence, RI 02908.

Received 2/ 6/92. Accepted 5/ 7/92.




This article has been cited by other articles:


Home page
JEMHome page
H. Kubagawa, S. Oka, Y. Kubagawa, I. Torii, E. Takayama, D.-W. Kang, G. L. Gartland, L. F. Bertoli, H. Mori, H. Takatsu, et al.
Identity of the elusive IgM Fc receptor (Fc{micro}R) in humans
J. Exp. Med., November 23, 2009; 206(12): 2779 - 2793.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-F. Lin, T.-C. Meng, P. S. Rao, C. Chang, A. H. Schonthal, and F.-F. Lin
Expression of Human Prostatic Acid Phosphatase Correlates with Androgen-stimulated Cell Proliferation in Prostate Cancer Cell Lines
J. Biol. Chem., March 6, 1998; 273(10): 5939 - 5947.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M.-C. Wang, J. H. Liu, and F.-F. Wang
Protein Tyrosine Phosphatase-Dependent Activation of beta -Globin and delta -Aminolevulinic Acid Synthase Genes in the Camptothecin-Induced IW32 Erythroleukemia Cell Differentiation
Mol. Pharmacol., April 1, 1997; 51(4): 558 - 566.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. P. Ramprasad, V. Terpstra, N. Kondratenko, O. Quehenberger, and D. Steinberg
Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein
PNAS, December 10, 1996; 93(25): 14833 - 14838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.